Protease Inhibitors from Marine Actinobacteria As a Potential Source for Antimalarial Compound

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2014 Mar 13

PMID 24618707

Citations 88

Authors

L Karthik

Gaurav Kumar

Tarun Keswani

Arindam Bhattacharyya

S Sarath Chandar

K V Bhaskara Rao

Affiliations

Soon will be listed here.

Abstract

The study was planned to screen the marine actinobacterial extract for the protease inhibitor activity and its anti- Pf activity under in vitro and in vivo conditions. Out of 100 isolates, only 3 isolates exhibited moderate to high protease inhibitor activities on trypsin, chymotrypsin and proteinase K. Based on protease inhibitor activity 3 isolates were chosen for further studies. The potential isolate was characterized by polyphasic approach and identified as Streptomyces sp LK3 (JF710608). The lead compound was identified as peptide from Streptomyces sp LK3. The double-reciprocal plot displayed inhibition mode is non-competitive and it confirms the irreversible nature of protease inhibitor. The peptide from Streptomyces sp LK3 extract showed significant anti plasmodial activity (IC50: 25.78 µg/ml). In in vivo model, the highest level of parasitemia suppression (≈ 45%) was observed in 600 mg/kg of the peptide. These analyses revealed no significant changes were observed in the spleen and liver tissue during 8 dpi. The results confirmed up-regulation of TGF-β and down regulation of TNF-α in tissue and serum level in PbA infected peptide treated mice compared to PbA infection. The results obtained infer that the peptide possesses anti- Pf activity activity. It suggests that the extracts have novel metabolites and could be considered as a potential source for drug development.

Citing Articles

In the battle of survival: transcriptome analysis of hypopharyngeal gland of the Apis mellifera under temperature-stress.

Maigoro A, Lee J, Yun Y, Lee S, Kwon H BMC Genomics. 2025; 26(1):151.

PMID: 39962388 PMC: 11834505. DOI: 10.1186/s12864-025-11322-5.

Dietary intake and risk assessment of nitrosamine in processed meat products among medical staff during their night shift.

Tayel D, Farrag N, Aborhyem S Sci Rep. 2025; 15(1):1898.

PMID: 39805899 PMC: 11730967. DOI: 10.1038/s41598-024-84059-y.

An Overview of Zika Virus and Zika Virus Induced Neuropathies.

Wahaab A, Mustafa B, Hameed M, Batool H, Tran Nguyen Minh H, Tawaab A Int J Mol Sci. 2025; 26(1.

PMID: 39795906 PMC: 11719530. DOI: 10.3390/ijms26010047.

Assessing the impact of intermittent fasting and a low-carbohydrate-high-protein diet on metabolic health and pancreatic histopathology in type 2 diabetic rat model.

Alqusayer A, Ahmed W, Althwab S, Hamad E Int J Health Sci (Qassim). 2025; 19(1):31-40.

PMID: 39760051 PMC: 11699238.

Determining the sensitivity and specificity of the calculated fatty liver index in comparison with ultrasound.

Saberian A, Dehghan A, Homayounfar R, Kaffashan S, Zarei F, Niknejad S BMC Gastroenterol. 2024; 24(1):443.

PMID: 39623301 PMC: 11610269. DOI: 10.1186/s12876-024-03535-x.

References

Pachebat J, Ling I, Grainger M, Trucco C, Howell S, Fernandez-Reyes D . The 22 kDa component of the protein complex on the surface of Plasmodium falciparum merozoites is derived from a larger precursor, merozoite surface protein 7. Mol Biochem Parasitol. 2001; 117(1):83-9. DOI: 10.1016/s0166-6851(01)00336-x. View

McCoubrie J, Miller S, Sargeant T, Good R, Hodder A, Speed T . Evidence for a common role for the serine-type Plasmodium falciparum serine repeat antigen proteases: implications for vaccine and drug design. Infect Immun. 2007; 75(12):5565-74. PMC: 2168336. DOI: 10.1128/IAI.00405-07. View

Yin H, Cao L, Xie M, Chen Q, Qiu G, Zhou J . Bacterial diversity based on 16S rRNA and gyrB genes at Yinshan mine, China. Syst Appl Microbiol. 2008; 31(4):302-11. DOI: 10.1016/j.syapm.2008.05.003. View

Maskey R, Helmke E, Kayser O, Fiebig H, Maier A, Busche A . Anti-cancer and antibacterial trioxacarcins with high anti-malaria activity from a marine Streptomycete and their absolute stereochemistry. J Antibiot (Tokyo). 2005; 57(12):771-9. DOI: 10.7164/antibiotics.57.771. View

Yeoh S, ODonnell R, Koussis K, Dluzewski A, Ansell K, Osborne S . Subcellular discharge of a serine protease mediates release of invasive malaria parasites from host erythrocytes. Cell. 2007; 131(6):1072-83. DOI: 10.1016/j.cell.2007.10.049. View

Vekemans J, Ballou W . Plasmodium falciparum malaria vaccines in development. Expert Rev Vaccines. 2008; 7(2):223-40. DOI: 10.1586/14760584.7.2.223. View

Drag M, Salvesen G . Emerging principles in protease-based drug discovery. Nat Rev Drug Discov. 2010; 9(9):690-701. PMC: 2974563. DOI: 10.1038/nrd3053. View

Ohno H, Saheki T, Awaya J, Nakagawa A, Omura S . Isolation and characterization of elasnin, a new human granulocyte elastase inhibitor produced by a strain of Streptomyces. J Antibiot (Tokyo). 1978; 31(11):1116-23. DOI: 10.7164/antibiotics.31.1116. View

. The biology of malaria parasites. Report of a WHO Scientific Group. World Health Organ Tech Rep Ser. 1987; 743:1-229. View

10.

Umezawa H, Aoyagi T, Morishima H, Matsuzaki M, Hamada M . Pepstatin, a new pepsin inhibitor produced by Actinomycetes. J Antibiot (Tokyo). 1970; 23(5):259-62. DOI: 10.7164/antibiotics.23.259. View

11.

Ritchie D, Kemp G . Protein docking using spherical polar Fourier correlations. Proteins. 2000; 39(2):178-94. View

12.

Bode W, Huber R . Natural protein proteinase inhibitors and their interaction with proteinases. Eur J Biochem. 1992; 204(2):433-51. DOI: 10.1111/j.1432-1033.1992.tb16654.x. View

13.

Demuth H . Recent developments in inhibiting cysteine and serine proteases. J Enzyme Inhib. 1990; 3(4):249-78. DOI: 10.3109/14756369009030375. View

14.

Karthik L, Kumar G, Rao K . Antioxidant activity of newly discovered lineage of marine actinobacteria. Asian Pac J Trop Med. 2013; 6(4):325-32. DOI: 10.1016/S1995-7645(13)60065-6. View

15.

Olson J, Lee G, Semenov A, Rosenthal P . Antimalarial effects in mice of orally administered peptidyl cysteine protease inhibitors. Bioorg Med Chem. 1999; 7(4):633-8. DOI: 10.1016/s0968-0896(99)00004-8. View

16.

McKerrow J, Sun E, Rosenthal P, Bouvier J . The proteases and pathogenicity of parasitic protozoa. Annu Rev Microbiol. 1993; 47:821-53. DOI: 10.1146/annurev.mi.47.100193.004133. View

17.

Suda H, Aoyagi T, Hamada M, Takeuchi T, Umezawa H . Antipain, a new protease inhibitor isolated from actinomycetes. J Antibiot (Tokyo). 1972; 25(4):263-6. DOI: 10.7164/antibiotics.25.263. View

18.

Putrianti E, Schmidt-Christensen A, Arnold I, Heussler V, Matuschewski K, Silvie O . The Plasmodium serine-type SERA proteases display distinct expression patterns and non-essential in vivo roles during life cycle progression of the malaria parasite. Cell Microbiol. 2009; 12(6):725-39. PMC: 2878606. DOI: 10.1111/j.1462-5822.2009.01419.x. View

19.

STAFFORD W, Gunder B, Harris A, HEIDRICH H, Holder A, Blackman M . A 22 kDa protein associated with the Plasmodium falciparum merozoite surface protein-1 complex. Mol Biochem Parasitol. 1996; 80(2):159-69. DOI: 10.1016/0166-6851(96)02696-5. View

20.

Aly A, Matuschewski K . A malarial cysteine protease is necessary for Plasmodium sporozoite egress from oocysts. J Exp Med. 2005; 202(2):225-30. PMC: 2213010. DOI: 10.1084/jem.20050545. View